Hoosier Cancer Research Network on Facebook

Hoosier Cancer Research Network on Facebook

OnCore Login
Login to Oncore Network

Login to Oncore Network

Hoosier Cancer Research Network on Facebook

Hoosier Cancer Research Network on Facebook

GU98-2

Weekly Paclitaxel and Gemcitabine in Advanced Transitional Cell Carcinoma of the Urothelium: A Phase II Hoosier Oncology Group Study

Abstracts/Posters/Presentations:

  • R. Parameswaran, Indiana University, Walther Cancer Institute, M. Fisch, M.D.Anderson Cancer Center, Walther Cancer Institute, C. Sweeney, L. Einhorn, Indiana University, Walther Cancer Institute. A Hoosier Oncology Group Phase II Study of Weekly Paclitaxel and Gemcitabine in Advanced Transitional Cell Carcinoma (TCC) of the Bladder: GU98-2. Accepted as a poster presentation for ASCO annual meeting May 12-15, 2001, San Francisco, CA.
  • Jinxing Li MD, Beth Juliar MA MS, Rafat Ansari MD, Edward Fox MD, Michael Fisch MD, Lawrence Einhorn MD, Christopher Sweeney MD. A Phase II Study of Weekly Paclitaxel (P) and Gemcitabine (G) in Advanced Transitional Cell Carcinoma (TCC) of the Urothelium): A Hoosier Oncology Group Study GU98-2. Accepted as a poster presentation at the ASCO annual meeting May 31-June 3, 2003, Chicago, IL

Manuscripts/Articles:

  • Jinxing Li, Beth Juliar, Constantin Yiannoutsos, Rafat Ansari, Edward Fox, Michael J. Fisch, Lawrence H. Einhorn, and Christopher J. Sweeney. Weekly Paclitaxel and Gemcitabine in Advanced Transitional-Cell Carcinoma of the Urothelium: A Phase II Hoosier Oncology Group Study GU98-2. J Clin Oncol 2005;23 1185-1191